Glessner Coleen sold EBS
October 7, 2025 · Form 4 insider transaction
Glessner Coleen sold 30,608 shares of Emergent BioSolutions Inc. at $10.00 per share, a transaction worth $306.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 9 days after the transaction.
Direction
Disposed (sell-side)
Shares
30,608
Price
$10.00
Total value
$306.1K
InsiderGlessner Coleen
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 7, 2025
Filing dateOctober 16, 2025
Shares owned after144,319
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on December 2, 2024 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act").; All shares sold at an exact price of $10.00.